Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-country Non-interventional Study on the Effectiveness of Empagliflozin in Adult Patients With Type 2 Diabetes in Europe and Asia.

NCT03817463 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03817463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03817463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-country Non-interventional Study on the Effectiveness of Empagliflozin in Adult Patients With Type 2 Diabetes in Europe and Asia.
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
April 15, 2019
Completion date
December 10, 2021
Enrollment
327,624 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2